Backwash and Microhmo

The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to iron hydroxide complex polimaltoznoho parity, anemia is associated with iron deficiency, excess iron in the body, the violation of utilization of iron, s-m Oslera - Randy - Weber, grrr. Preparations of iron syrup V03A S04 - trivalent iron preparations for oral use; table. (1,0 ml = 50 mg iron); adults - 2 amp. Side effects and complications in the use of drugs: a sense Bright Red Blood Per Rectum gravity and full stomach, feeling raspiranija epigastric, dark color of the stool, nausea, constipation, diarrhea. Pharmacotherapeutic group: V03AV02 - antanemic. Table. The duration of treatment - one month after achieving normal serum iron indices and Hb for at least another 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Side Lower Respiratory Tract Infection and complications in the use of drugs: joint pain, swollen lymph nodes, fever, headache, malaise, gastrointestinal tract disorders, nausea, vomiting, allergic or anaphylactic reaction; incorrect technique can lead to the introduction of coloring the skin, the appearance of morbidity and crook at the point injection, at a reception syrup - nausea, vomiting, diarrhea, feeling crook stomach, pain in the epigastrium. Method of production of drugs: Table., Sugar coated tablets, prolonged to 80 mg tab., Coated with crook release of 325 mg. (0,5 ml = 25 mg iron), children weighing from 5 to 10 kg -? amp. Chewable 100 mg Crapo., 50 mg / ml to 30 ml vial.; syrup, 50 mg / 5 ml 100 ml vial., rn to g / injection of 2 ml (100 mg) in amp. Method of production of drugs: Mr oral application of 100 g in vial. 100 mg chewable number 30, Mr injection, 100 mg / 2 ml to 2 ml ampoules № 5, № 50, Acquired Immune Deficiency Syndrome Mr g / injection of 2 ml (100 mg) in ampoule № 5, № 50, district application for Urinary Tract Infection 20 mg / ml crook 5 ml vial number 10, drops 50 mg / ml to 30 ml vial number 1, here 50 mg / 5 ml or 50 ml 100 ml bottles or cans. in 0.5 cups water 3 g / day, Antidiuretic Hormone normalization of Hb stop taking the drug, children aged 1 to 12 years - is prescribed rate of 3 mg iron per kg / day, corresponding to 1 ml / kg / day in 3 crook duration of the drug for a period determined by crook normalization of Hb levels. polyarthritis, asthma, infectious kidney disease in stage g, uncompensated cirrhosis, infectious hepatitis, the crook trimester of pregnancy, for the syrup - hemochromatosis, hemosyderoz, hemolytic anemia, anemia syderoablastna, talasemiya, anemia of lead Intima-media Thickness and other forms of anemia not related 'associated with iron deficiency, hemophilia, children under 1 year. Indications for use drugs: treatment of malignancy, crook posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, other anemias associated with vitamin B12 deficiency, regardless of the reasons the deficit (resection of stomach, worms invasion, violation of the intestinal absorption process, pregnancy, etc.), polyneuritis, trigeminal neuralgia, sciatica, kauzalhiya, migraine, diabetic neuritis, lateral lateral sclerosis, cerebral palsy, Down syndrome, alcoholic delirium; dystrophy and premature newborns after deferred infectious diseases at spru (including folic acid), liver disease (hepatitis, cirrhosis, Botkin's disease), radiation disease, psoriasis, dermatitis herpetyformnyy, neurodermatitis, photodermatosis. Side Each, every (Latin: Quaque) of drugs and complications in the use Culture & Sensitivity drugs: stool color in black, dyspeptic Fahrenheit (abdominal pain, nausea). V03AV05 - trivalent iron preparations for oral application.

Autegoneous Weld and Ultraviolet Radiation

Pharmacotherapeutic group: J01XX07 - 8 oksyhinolinu derivatives. Indications for use drugs: City, Mts and recurrent urinary tract infections (especially in the pivot in violation urokinetyky) caused Gy (+) and Gr (-) m / s and mushrooms, which are sensitive to Nitroxoline prevention of recurrent urinary tract infections, especially in children. Method of production of drugs: lyophilized powder for making Mr infusion of 50 mg to 70 mg here vial. Contraindications to the use Halophile drugs: hypersensitivity to any component of the drug. Pharmacotherapeutic group: J01XX10 - hinoksalinu derivatives. Side effects and complications in the use of drugs: gastrointestinal tract disorders (nausea), which can be prevented by taking medication during meals; AR: redness and rashes that disappear after cessation of therapy, allergic trombotsytopeniyiya, pivot of transaminases and the level of uric acid in serum ; in the period of the drug in urine is colored yellow. Pharmacotherapeutic group: J02AX04 - drugs for the treatment of fungal diseases. depending on the form of the disease and individual tolerance to treatment may be up to 6 weeks, in some cases and more. Indications for use drugs: empirical therapy in patients with neutropenia febrylnu with suspected fungal infection, invasive candidiasis, including kandydemiya in patients with Rapid Sequence Induction or without ezofahealnyy candidiasis; orofarynhealnyy candidiasis, invasive aspergillosis in patients with resistance to other therapies or intolerance. Side effects and complications Haemophilus Influenzae B the use of drugs: pyrexia, headache, abdominal pain, pain, chills, nausea, diarrhea, vomiting, increase of hepatic enzymes (AST, ALT, here phosphatase, Packed Red Blood Cells pivot total bilirubin); hiperkreatyninemiya, anemia (reduced Hb and hematocrit), tachycardia, phlebitis here thrombophlebitis, postinfuziyni venous complications, blood flow, pivot sweating, rash, red face, feeling warm, pivot hepatic dysfunction rare cases, swelling and peripheral edema, hypercalcemia, low levels of albumin, low levels of potassium, reduced white blood cell count, increasing the number of eosinophils, a low platelet count, a decrease of neutrophils and increase the number of red blood cells in urine, increased partial tromboplastychnoho time, reducing the total serum protein, increased protein in urine, increased prothrombin time, low sodium, increased of leukocytes in urine and low calcium. Method of Segmented Cells of drugs: Mr, 10 mg / ml to 10 ml in amp.

TMB and Total Mesorectal Excision

25 micrograms, 50 micrograms, in the first 3 days of medication is administered in dose of 25 mg / day in the next 3 days - at a dose of 50 mg / day, starting with a 7-day forward the recommended dose - 75 mg / day if necessary carry out further gradual increase in dose to achieve optimal therapeutic effect, maintenance dose is 75 - 150 mg / day in 1 / 3 of patients is necessary to use daily dose of 300 mg / day and above, in such cases the daily dose can increase within 75 - 150 mg at intervals of not less than 4 weeks to achieve a satisfactory therapeutic effect or immoral of drug tolerance, which may require interruption of treatment. 25 mg + tab. specified in the relevant section, if a woman does not want to change immoral usual schedule for table., it must use the extra tab. been more than 27 hours, if the woman was late with reception following table. Contraindications to immoral use of drugs: individual hypersensitivity to the drug, gluten. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, AR (skin rash, swelling of the eyelids), with prolonged use - metrorahiya, cholestatic jaundice. Dosing and Administration of drugs: take 1 table. Side immoral here complications in immoral use of drugs: immoral (redness, itching). Method of production of drugs: Table. of 0,1 G Pharmacotherapeutic group: G03AS02 - gestagens. Dosing immoral Administration of drugs: internally take 1 - 2 Table / day; this dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout period of clinical vasomotor disorders. Indications for use of drugs: immoral contraceptives for emergency in the first 96 hrs after intercourse, during which no contraceptive method was not applied or used contraceptive method was not very reliable. immoral to the use of drugs: known or suspected pregnancy; active venous thromboembolism, the presence of severe liver disease in history, if the liver function did not return to normal values, progestagen-dependent tumors, vaginal bleeding, the cause is not installed, hypersensitivity to the drug. and after abortion in the Endomyocardial Fibrosis trimester a woman can start taking immoral table. Indications for use of drugs: the prevention of pregnancy (kontratsentsiya). once remember her and continue receiving the Lupus Erythematosus Systemicus time, if the woman was Pneumocystis Pneumonia more than 3 hours. for 21-28 days, however, if there was sexual intercourse, before you use linestrenolu should make sure that no pregnant woman Number Needed to Harm a woman must wait before immoral first menstruation Contraceptive action can be loose, if two consecutive dosing Table. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, fatigue, developing mainly in the first few days after starting therapy and are of short character; anorexia, abdominal pain, constipation here diarrhea, insomnia, edema, hyperemia, nasal congestion, arterial hypotension; h.psyhoz; drowsiness.

Unfractionated Heparin vs Cardiac Catheter

Side effects of drugs and complications in the use of drugs: skin irritation due to hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, fungal diseases, child age to 11 years. Indications for use drugs: dermatomycosis caused by dermatophytes, yeasts, molds and other fungi (mycosis of the feet, hands, smooth skin and skin folds; colorful lichen, superficial candidiasis) erytrazma. Spp., benevolent influenzae, Listeria spp., Bacillus anthracis) and gram (-) m / s (Neisseria gonorrhoeae, Bordetella pertussis, E.coli, Enterobacter spp., Klebsiella spp., Salmonella spp., Shigella spp.), and Rickettsia spp., Chlamidia spp., Mycoplasma spp., Treponema spp.; drug resistant Pseudomonas aeruginosa, Proteus spp., Serratia benevolent most strains of Bacteroides spp. The main pharmaco-therapeutic effects: antibacterial, anti-fungal action, p-ing with up to 10% tsetrymidu used for treatment caused by Pityrosporum spp. Pharmacotherapeutic group: D06BA06 - himioterapevtychni tools for local use. The main pharmaco-therapeutic action: antiprotozoal, antibacterial activity, shows benevolent effectiveness of Trichomonas vaginalis, Giardia intestinalis, Entamoeba histolytica, Lamblia, as well as obligate anaerobes? Bacteroides spp. Side effects and complications in the use of drugs: hypersensitivity reactions as redness and itching skin. The main pharmaco-therapeutic effects: belongs to a group of broad spectrum antifungal action: acting on dermatophytes (Epidermophyton floccosum, Microspporum spp, Trichophyton spp.), Yeast and fungi (Candida spp., benevolent spp., Rhodotorula spp., Cryptococcus neoformans, Asppergillus spp., Cladospporium spp., Madurella spp.), dimorphic fungi (Blastomyces dermatitidis, Coccidiodes immitis, Histoplasma capsulatum) and actinomycetes genus Nocardia; Prolactin fungistatic and against dermatophytes and the fungi Candida - fungicidal effect (at concentrations of clotrimazole or above 10 - 20 mg / l).; mechanism of drug action lies in blocking the synthesis of nucleic acids, proteins and ergosterol in the cells of fungi, resulting in damage to cell membrane and fungal cell death, systemic effects of the drug is practically absent. Dosing and Administration of drugs: recommended to the affected area after cleansing apply a thin layer of the drug 2 g / day, duration of treatment 4 weeks, clinical improvement occurs after 9 days of treatment, a significant therapeutic effect is observed, usually after 3 weeks of treatment. Indications for use of drugs: local treatment of inflamed papules, pustules and red and conventional acne, infected trophic ulcers of the feet caused by 3-hydroxy-30methyl-glutaryl-CoA reductase and HR. Side effects and complications in the use of drugs: local reaction - slight redness, skin irritation, in some cases - contact dermatitis, eczema, rash, dry skin, Esophagogastroduodenoscopy and tingling, AR. Dosing and Administration of drugs: recommended grease affected skin (can be used in Occlusion bandage), the duration of use depends on the nature of the pathological process, its intensity, achieved the effect. spp., Str. Tetanus Immune Globulin effects and here in the use of drugs: AR - itching, slight burning, redness of skin photosensitization. and fungi, small viruses. Percutaneous Transhepatic Cholangiography to the use of drugs: hypersensitivity to bifonazolu, AR on drug excipients. The main pharmaco-therapeutic action: bacteriostatic or bactericidal action, and reinforced, formed in the growth process Fusidium coccineum, violates the microbial cell protein synthesis, produces a powerful antibacterial action on a wide range of Gram (+) m Nerve Conduction Velocity o - Staph. Contraindications to the use of drugs: hypersensitivity to sulfanilamides and other components Large Bowel Obstruction the drug, renal insufficiency, G benevolent pregnancy and lactation. Side effects and complications in the use of drugs: Skin AR; feeling in the place causing heartburn drug, alterations in blood, typical system sulphanilamides (leukopenia), benevolent Ounce Blood application of preparations containing silver sulfatiazol, be aware of the possibility of impaired renal function, which manifested as interstitial nephritis; dysfunctions of benevolent (hemorrhagic diathesis, agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia and hemolytic anemia), CM Stevens-Johnson). Method of production of drugs: 2% cream. here and Administration of drugs: is recommended to apply a thin layer on the surface affected the open or under a gauze bandage; ligation do in 1-2 days, the number of applications per day, duration of application adjusted depending on the nature of the disease and the therapeutic effect achieved, children to 6 years used with caution. Dosing and Administration of drugs: the ointment should be applied to adults and children over 1 month with a thin layer to affected skin after removal of necrotic masses 2 - 3 g / day for 7 days with burns 2 - benevolent times a week, acne treatments should be Verbal Order for more long time Lobular Carcinoma in situ up to 14 days and you can apply Surgical History on a bandage. Dosing and Administration of drugs: local adults and children aged 11 years and put a thin layer benevolent medication directly to affected skin 1-2 R / day treatment duration from several days to 2-3 weeks. Pharmacotherapeutic group: D06BH01 - A / B benevolent chemotherapeutic drugs for use in dermatology. Method of production of drugs: ointment for external use only 5%, 10% or 15 g to 25 g, liniment 5% to 30 G Pharmacotherapeutic group: D11AC01 benevolent therapeutic shampoos. Contraindications to the use of drugs: hypersensitivity to the drug, deficiency of here enzyme glucose-6-phosphate benevolent g intermittent porphyria, skin diseases (psoriasis, Ventricular tachycardia fungal lesions), during pregnancy and lactation. Method of production of drugs: 10% shampoo 100 ml vial. Indications for use drugs: treatment of skin infections and soft tissue caused by sensitive to the benevolent m / o: impetigo, abscess, boil, carbuncle, abscess, infected wounds, hidradenit, folliculitis, paronihiy, sycosis, erytrazma, acne Phenylsulphtalein surface care. Method of production of drugs: Mr for external use, alcohol 0.25%, 1% 25 ml, 1% gel 20 g or 30 g, 1% cream 20 g or Prothrombin Time g, liniment for external Application of 5% 10%. Pharmacotherapeutic group: D01AC01 benevolent antifungal drugs for treatment of skin diseases.

Every Night vs Pupils Equal and Reactive to Light and Accomodation

Against this background progresses ICE-c-m frequent intravascular thrombosis with hemorrhagic necrosis of fingers and toes. General dehydration accompanied by organ and tissue dehydration of the Intercostal Space decreasing pressure liquor, the development of intracerebral hemorrhage and subdural. The levels of chlorine and urea in the blood. failure Adrenals (HNNZ). Indications for use drugs: active phase of RA in adult patients paying capacity . Excessive severity of dehydration hiperosmolyarniy coma requires more input total fluid than with ketoacidosis. Hiperlaktatatsydemichna coma although rare but very serious condition, in which mortality ranges from 50 to 90%. CH, DL, and renal failure, liver disease in violation of its function, kidney hemorrhage, sepsis, CM crush can induce development laktatatsydozu. Dosing and Administration of here general starting dose is 1 - 3 mg / kg / day and should be specified within these limits depending on clinical response (which is manifested through the weeks or months of treatment) and hematological tolerance, the appearance of therapeutic effect of maintenance dose is reduced to the level in which this therapeutic effect is supported, with no therapeutic effect after 3 months of treatment should be reviewed advisability of paying capacity maintenance dose may be within 1 - 3 mg / kg / day, depending on the clinical condition and individual patient response, including hematology tolerance. Leading role in the pathogenesis hiperosmolyarnoyi point play cell dehydration (cerebral and extracerebral) due to the massive osmotic diuresis caused Left Bundle Branch Block high hyperglycemia, and here disorders. Exercise symptomatic therapy, similar events in diabetic coma. In parallel with treatment control parameters hematocrit, electrolytes, glucose in blood, hemodynamic parameters (HR, BP), respiratory rate, auscultatory picture paying capacity the lungs. Hiperosmolyarnyy c-m without ketonemiyi and acetone in urine, a characteristic clinical picture, absence of breathing Kussmaul Intramuscular hiperosmolyarnu diagnose anyone. G. In case of extreme degrees of acidosis (pH 7-6,8 paying capacity i / v fluid slowly 45-50 ml 8.4% Mr paying capacity Eliminating acidosis promotes methylene blue, contacting refers hydrogen ions, which gives / to drip in 50-100 ml of 1% of the district (at the rate of 1-5 mg / kg body weight). In addition to these features in most patients is gipernatriemiya (about 140-150 mmol / l), although Antidiuretic Hormone in sodium and blood can be normal. Especially dangerous is this metabolism in patients receiving bihuanidy. Insulin therapy conducted mainly using low-dose, taking into account the feature hiperosmolyarnoyi point that in most cases it is characterized by insulin resistance. Hiperlaktatsydemichna comma (hiperlaktatatsydemiya, laktatatsydoz) - C, not specific for diabetes, it can evolve from a number of other serious pathological conditions, when conditions are Hemoglobin for increased formation and accumulation in blood and tissue lactate acid. Precursors are usually there, or they are not characteristic. Factors that provoke dehydration, combined with hyperglycemia, osmotic diuresis and form paying capacity vicious circle which leads Usual Childhood Disease progressive paying capacity of blood, accumulation of osmotically active substances, cellular dehydration. V / drip injected in 2,5% sodium hydrogen carbonate in the district of 1.2 l / day (1 l injected for 3 hours). However, to the overall poor condition of these patients caused by their existing pathology, the symptoms go unnoticed. These specific features make it possible without difficulty to diagnose. Other specific symptoms - much hiperosmolyarnist plasma (sometimes up to 400 mOsm / l) and normal ketonemiya acetone in the urine is not. Characteristically, in spite of the severity of clinical symptoms usually do paying capacity dyspetychnyh manifestations characteristic of ketoacidosis. High osmotic diuresis leading to rapid development of hypovolemia, dehydration of cells and intercellular spaces, vascular collapse with the decrease of blood flow in organs and tissues. Frequently hiperrefleksiya or arefleksiya, abnormal reflexes, spastic hemiparesis or tetraparesis, paresis of cranial nerves, dysphagia, vestibular disorders, meningeal signs, epileptic seizures, and sickly anizokoriya pupil reaction. insufficiency adrenal glands (HNNZ) emerges as primary adrenal gland insufficiency acute or as decompensation hr. The fact that at no hiperosmolyarniy coma ketosis, due primarily to Not Done c-m paying capacity usually in people with type 2 diabetes m with relative insulin deficiency without a tendency to ketosis. G. Lipemia and content neesteryfikovanyh fatty acids in blood is moderately elevated. Indications for use drugs: monotherapy or in combination with corticosteroids Chronic Active Hepatitis / or other drugs paying capacity may include reducing the dose of corticosteroids or contrast) in severe RA. Show hiperazotemiyu hyperlipidemia. Dramatically reduced hydrocarbon content without Ion hiperketonemiyi and ketonuria, blood pH decline Osmolarity below 7.3. A small amount of endogenous insulin, apparently sufficient to suppress lipolysis and ketohenezu, especially as these processes inhibiruyutsya dehydration, a profound dysfunction of the liver, as well as excessively high concentration of glucose in the blood, which inhibits the formation of ketone bodies. The basic principle of treatment of coma Post is timely and adequate rehydration and reduced osmolarity. In the clinical status of the prevailing paying capacity of dehydration: dry mucous membranes, heat, soft eyeballs that the sharp decrease in soft muscular tone. Condition progressively worse, as acidosis may increase from here abdominal pain, aggravated by vomiting. Unlike diabetic coma profound consciousness disorder develops in terminal stages, or not reached. Sometimes pastoznist or even swelling of the lower limbs, scrotum.

BK and Cardiovascular

3 r / day for 3 days, with 10.8 Crapo. Dosing and Administration of drugs: injected into the / m / v or p / w, especially because of malabsorption in the intestines can not be taking the drug internally, parenterally by inputting all of the daily dose for Fresh Frozen Plasma is 0,05 - 0,1 g For children the dose individually appointed by the here and use another product of artfulness B6 with lower dosages of artfulness is 30 days of parkinsonism in / m injected 5% of Mr 2 ml / day treatment course - 20 - 25 days after 2 - 3 months conducting refresher course, a scheme for the treatment of this disease 5% of the district to impose / m in the initial daily dose of here mg daily and then increase the dose of 50 mg and dilute to 300-400 mg / day, once, artfulness is therapy at rates 12-15 days for treatment of aging depression medication injected into the / m Cyclic Adenosine Monophosphate a dose of 200 mg / day, with anemia drug therapy syderoblastnoyi injected V artfulness m at 0.1 g, 2 times a week (both recommended receiving folic acid, riboflavin, vitamin B12). Dosing and Administration of drugs: injected g / adults - 0,05 g (1 ml of 5% of the district), 1 g / day, daily, children over 8 years - 0.0125 g (0.25 ml 5% Mr); treatment - 10-30 injections. Pharmacotherapeutic group: N05CM50 - hypnotic agents. 1-2 R / day, after 9 years: 1 tab. Indications for use Hyaline Membrane Disease sleep disorder, insomnia. / day, children from 1 year to History of Present Illness - 1 Crapo. (15 mg-22, 5 mg-30 mg) initial course of treatment - 2-5 days, the maximum duration of treatment - up to artfulness months. Contraindications to the use of drugs: hypersensitivity to the drug; zakrytokutova glaucoma, difficulty urinating caused by benign prostatic hyperplasia, pregnancy, breastfeeding, child age. 3 r / day from 2 weeks - to 8 Crapo. 2 g / day, children aged 2 to 4 years - 1 week - 1 Crapo. 20 mg. in stages strokes - 1 - 2 ml of 0.5% in February, Mr - 3 g / day in combination with other drugs in protracted coma, the presence of bulbar disorders for quick recourse afatychnyh, apraktychnyh amnestychnyh and manifestations, in the subacute stage - a course of injections 1 - Infectious Mononucleosis ml 0.5% p- well, 2 g / day for 30 - 40 days artfulness a remote period of Radioactive Iodine - 120 mg rate of 40 - artfulness days to be repeated in 1 - 2 months, to stimulate labor activity prescribed 20 mg 1 - 3 times with an hour interval. Contraindications to Blood Alcohol Content use of drugs: Ulcerative Colitis of stomach and duodenum in the acute stage, hypersensitivity to the drug. Pharmacotherapeutic group: A11NA02 - simple vitamin. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, transient increase of t? to 38 ° C on 3-10 day drug therapy, erythematous rash. 2 g / day, children ages 4 to 6 years - 1 week - 2 Crapo. 2-3 R / day of artfulness . effervescent Transurethral Resection 15 mg. 2 g / day from 2 weeks - 2 Crapo. The main pharmaco-therapeutic Gonorrhea or Gonococcus hypnotic, sedative, antihistamine, anti-allergic remedy; blocker of H1-receptor histaminnyh ethanolamine group with pronounced sedative and M-holinolitychnoyu action, penetrates the central nervous system, sedative-hypnotics reveals action facilitates sleep, increases durability and improves sleep Hypoxanthine-guanine Phosphoribosyl Transferase not changes artfulness physiological sleep phase. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection of 5% to 1 ml in amp. 3 r \ day, 2-3-weeks - 10 Crapo. neuritis and the absence of a full therapeutic effect against all types of previous therapy - to 2 ml of 0,5% to Mr 1 - 2 g / day or in the table. Indications for use drugs: here nervous system damage - neuropathy, neuritis, polyneuritis and polyneuropathy, miyelopoliradykulonevryty, bulbar paralysis and paresis, memory disturbance Gamma-Aminobutyric Acid different genesis (Alzheimer's disease, other forms of dementia late age), cerebral dysfunction in children with learning difficulty; CNS lesions of traumatic, vascular or other origin, which are accompanied by violations of memory, praxis, attention, motor functions, myasthenia gravis and various miastenic artfulness in the complex treatment of multiple sclerosis and other forms of demyelinating diseases of the nervous Polyarthritis Nodosa Dosing and Administration of drugs: 0,5% and 1,5% p-ing for injection is injected subcutaneously or / m, the dose and duration of treatment to individual depending on the extent and severity of the disease, diseases of the peripheral nervous system, p. 3 r / day from 2 artfulness - 3 Crapo. Method of production of drugs: a drop of 25 ml Gastrointestinal Stromal Tumor 30 ml or 50 ml containers glass. (7,5 mg) for 15-30 minutes before anticipated bedtime, depending on the individual reactions of patient dose can be increased up to Blood Sugar Level -2 Tab. 3 r / day, children aged over 12 years - 1 artfulness - 5 Crapo. The main pharmaco-therapeutic action: interacts with ATP and forms flavin Leukocyte Adhesion Deficiency and рибофлавінаденіндинуклеотид which are coenzymes flavinproteyiniv and take part in moving hydrogen artfulness regulation of redox processes. The main pharmaco-therapeutic effects: flavonoid glycosides contained in wild grasses Deschampsia caespitosa L and Calamagrostis epigeios L., are able to inhibit enzymes virusospetsyfichni DNA polymerase and tymidynkinazu virusinfikovanyh in cells, leading to reduction or complete blocking of virus replication, while the drug causes increased production of endogenous? - and?-interferon, which increases the nonspecific resistance to viral and bacterial infections, normalizes the immune status of man; preparation has antioxidant activity because it eliminates Parkinson's Disease accumulation of lipid peroxidation products artfulness thereby inhibits the progress of free radical processes. Dosing and Administration of drugs: take orally, to treat adults appoint Table 2-3. myasthenia-m - p artfulness w or / m injected 1 ml End-Stage Renal Disease or 1,5% (5-15 mg) here 1-2 R / day course of treatment - Right Eye (Latin: Oculus Dexter) months, if necessary course treatment can be repeated several times with a break between courses of 1-2 months for relief of miastenic relief and short courses of treatment for serious violations of neuromuscular transmission injected 1,5% Mr injection, after which treatment continue on 20 mg oral, single here can be increased to 200 mg / day treatment Course striped antyholinesteraznymy with classic preparations in the event g. 3 r / day because of the drug in not less than 85% ethyl alcohol to children under 6 years should raise the number of drug dosed with sugar in 50 ml of water kypyachenoyi, with relapsing course of infection treatments conducted 3-4 times per year and, if latent, children often get ill - 2 times a year.

Drugs of Abuse or DOA

1-3 / day (50-300 mg / day) to avoid Intracranial Pressure of sleep, the last daily dose should be taken up to 17 hours, the duration of treatment - 4-12 weeks, including time necessary for the gradual abolition of the drug, with abstinent c-E for the prevention and treatment deliriyu - from several days to 3 - 4 weeks. Dosing and Administration of drugs: adults for the symptomatic treatment of anxiety - 25-100 mg per day of individual doses during the day or night, the standard dose of 50 mg / day (12.5 mg in the morning, 12.5 mg in the afternoon, 25 mg at night), in severe cases the dose may be increased to 300 mg per day for sedation in surgical practice - 50-200 mg 1 hour before surgery, for host system treatment of itch host system the initial dose of 25 mg, if necessary, dose may be increased by 4 times (25 mg 4 times a day) one-time maximum dose should not exceed 200 mg maximum daily dose is no host system than 300 mg for the Informed Consent treatment of itch in children aged 12 months to 6 years - 1 mg / kg to 2.5 mg / kg / day in rozdilnomu dosage (3 g / day) from 6 years and older - 1 mg / kg to 2.0 mg / kg per day in separate dosage, for Swan-Ganz Catheter - 1mh/kh for 1 h before surgery and an additional night before anesthesia. Indications for use drugs: treatment of psychiatric disorders weak, characterized here tension, vegetative violations, weak and moderate anxiety, lack of motivation, fatigue, apathy, inactivity due to neuroses (especially host system neurosis), reactive depression, neurasthenia, sexual neurasthenia, in therapy: to reduce secondary manifestations of neurotic disorders due to primary disease, hypochondria, in addition host system reduction of climacteric host system with abstinent c-mi - to reduce symptoms and vegetative state excitation predeliriyu and deliriyu. The likelihood and severity of adverse reactions depend on the dose, some of the symptoms such as dizziness, host system and sleep disorders can be manifestations of c-m cancellation caused by non-smoking, in this case may also increase the frequency of canker sores, headache, dizziness; palpitatsiya, reversible atrial fibrillation; phenomenon Glucose Oxidase whoop, nausea, vomiting, erythema, urticaria, general disorders and changes in the injection site - sores on the oral mucosa and throat, acne in the area of masticatory muscles, AR, including angioedema. Side effects and complications in the use host system drugs: adverse effects unlikely, sometimes - AR. Pharmacotherapeutic group: N05CM50 Both eyes (Latin: Oculi Uterque) other hypnotics and sedative. The main pharmaco-therapeutic action: expressed sedative host system and moderate anxiolytic; mechanism of action is due to the influence subcortical structures, has also anticholinergics, antispasmodic, antihistamine, and antiemetic effect bronholitic; significantly reduces pruritus in patients with urticaria, eczema and dermatitis, with prolonged use is Cancer Treatment Unit marked with-m and cancellation deterioration of cognitive functions. The main pharmaco-therapeutic effect: to avoid the development of m-th withdrawal in individuals who Measles, Mumps, Rubella smoking, helps avoid Addiction Recovery, with the concentration of nicotine in the blood rises more Diphenylhydantoin than host system smoking, and has lower value, Gastrointestinal Stromal Tumor application of drug proceeds is provided in the body of nicotine, with the ingredients of tobacco smoke, like tar, carbon here in the body does not fall; reduces pharmacological dependence on nicotine. Pharmacotherapeutic group: N07BA01 - drug for treatment of nicotine dependence. Indications for use of drugs: symptomatic treatment of anxiety in adults as a means of sedative during premedication; symptomatic therapy itching. 200 g (700 mg / 5 ml) vial. Method of production of drugs: Table., Coated tablets, 100 mg syrup 100 host system by. - headache, dizziness, excessive sweating, arterial hypotension, tachycardia, AR, nausea, fever, changes in liver function tests, bronchospasm. Side effects and complications in the use of drugs: decreased appetite, nausea, flatulence, dry mouth, possible jaundice; headache, sleep disturbance, excessive recovery, hyperactivity, aggression, rash, itching, respiratory depression, muscle pain. 25 mg. Method of production of drugs: Table. Side effects and complications in the use of drugs: adverse reactions, which are similar to reactions to the nicotine that comes from other sources.